Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl‑2 and Mcl‑1

Documenti analoghi

• Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
  di: Murray, James B., et al.
  Pubblicazione: (2019)
• S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
  di: Casara, Patrick, et al.
  Pubblicazione: (2018)
• Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x(L)
  di: Gautier, F., et al.
  Pubblicazione: (2011)
• Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
  di: Moujalled, Donia M., et al.
  Pubblicazione: (2020)
• Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-x(L)/Bcl-2 in Mcl-1–expressing myeloma cells
  di: Morales, Alejo A., et al.
  Pubblicazione: (2011)